The president of AstraZeneca’s China division has been placed under investigation by local police, as Beijing advances an anti-corruption crackdown in the healthcare sector. The British ...

AstraZeneca’s China president is under investigation in mainland China, the drug company said on Wednesday. Leon Wang was described as cooperating “with an ongoing investigation”, the ...

BEIJING - The head of multinational pharmaceutical giant AstraZeneca’s China arm is under investigation in the country, the firm said. Mr Leon Wang, president of AstraZeneca China, is ...

British-Swedish drugmaker AstraZeneca confirmed on Wednesday that its China President Leon Wang is under investigation by Chinese authorities, marking the latest probe into the pharmaceutical ...

BEIJING—An investigation involving a top executive at drugmaker AstraZeneca AZN-0.18%decrease; red down pointing triangle is the latest to rattle foreign companies in China, where a series of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-based drug for cancer.

AstraZeneca has confirmed that some of its current and former employees have been taken into custody in China as part of an investigation into data privacy breaches and the import of unlicensed ...

AstraZeneca said its China president Leon Wang is under investigation and the drugmaker would cooperate with Chinese authorities. The company did not say what the investigation was about or whether ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 18,877.38 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...